Leishmania -- Case studies : Case studies in infectious disease : Leishmania spp. / Peter M. Lydyard [and others]
2010
1
Leishmania -- drug effects : Drug resistance in leishmania parasites : consequences, molecular mechanisms and possible treatments / Alicia Ponte-Sucre, Emilia Díaz, Maritza Padrón-Nieves, editors
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL)
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL)
A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL)
A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms
1
Leishmaniasis -- See Also the narrower term Kala-azar
Leishmaniasis -- prevention & control : Leishmania : current biology and control / edited by Subrata Adak and Rupak Datta ; contributors, Subrata Adak [and thirty-three others]
Leishmaniasis, Visceral : Challenges and solutions against visceral leishmaniasis / Angamuthu Selvapandiyan, Ruchi Singh, Niti Puri, Nirmal K. Ganguly, editors
